Keywords: introgen, r-pr, gene, therapy, deal, therapeutics, entered

Introgen And R-PR Gene Therapy Deal

Article | 07 November 1994

Introgen Therapeutics has entered into a strategic agreement with Rhone-Poulenc Rorer to develop and commercialize gene therapy cancer products based ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Antihemophilic Factor

Recombinant

Coagulation Factor VIIa

Go to drug listing